About Eminent Biosciences
Eminent Biosciences is a Healthcare company based in Indore (India) founded in 2008. It offers bioinformatics analysis, sequencing services, and training for life sciences research. It operates on a B2B model. Its Indian entity Legene Biosciences Private Limited reported revenue of ₹1.3 Lakh. Eminent Biosciences offers products and services including PDB Explorer, KodDNA, and Journal Search Engine. Its focus areas include Biotechnology, Microbial Informatics, Metagenomics and 16S rRNA Sequencing.
Company details
Eminent Biosciences is a private research organization established in 2008, focusing on biotechnology, bioinformatics, and healthcare informatics. It delivers services like next-generation sequencing, data analysis, and microbial informatics to support life science and pharma industries. Based primarily in Indore, India, with a US presence, it emphasizes high-performance computing and training for researchers, ensuring quality and reliability in computational biology.
- Headquarters Indore, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website eminentbio.com
- Social Facebook
- Legal Name Legene Biosciences Private Limited
- Date of Incorporation 09 Jan, 2017
- Jurisdiction Indore, Madhya Pradesh, India
- Annual Revenue₹1.3 Lakh
FY 2025 · -91% YoY
- Net Profit₹9,960
FY 2025 · 8% margin
- EBITDA₹16,985
FY 2025 · 13% margin
Associated legal entities of Eminent Biosciences
Eminent Biosciences operates through Legene Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Legene Biosciences Private Limited CIN U74999MP2017PTC042165 | Active | 09 Jan 2017 | Indore, Madhya Pradesh | ₹0.0 Cr | 2 | View details |
Products & Services of Eminent Biosciences
Eminent Biosciences offers a comprehensive portfolio of products and services, including PDB Explorer, KodDNA, and Journal Search Engine.
Web-based tool for visualizing and annotating protein structures.
Software for DNA and protein sequence assembly and analysis.
Online engine for finding biotechnology and bioinformatics articles.
Board of directors of Legene Biosciences Private Limited (Eminent Biosciences)
Legene Biosciences Private Limited is the primary company behind Eminent Biosciences. The board of Legene Biosciences Private Limited currently have 2 directors; the longest-serving is Rini Krishnan Karthikeyan, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rini Krishnan Karthikeyan DIN 07653502 | Director | 09 Jan 2017 | 9 yrs 9 mo | Legene Biosciences Private Limited |
| Anuraj Nayarisseri DIN 07653520 | Director | 09 Jan 2017 | 9 yrs 9 mo | Legene Biosciences Private Limited |
People of Eminent Biosciences
5 people are tracked at Eminent Biosciences (1 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
| Founder/CEO | Leadership | |
Akanksha Limaye | Bioinformatics Analyst | Team |
Dr. Anuraj Nayarisseri | Principal Scientist | Team |
Abhishek Kumar | Bioinformatics And NGS Analyst | Team |
Kalpita Tanwar | Bioinformatics Analyst | Team |
Complete people profiles for Eminent Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Eminent Biosciences
Figures of Legene Biosciences Private Limited, the primary company behind Eminent Biosciences, for FY 2025. Revenue was ₹1.3 Lakh (-91% year on year). Net profit was ₹9,960 (8% margin). EBITDA was ₹16,985 (13% margin). Revenue has grown at a compounded annual rate of +3% over three years and +9% over five years.
- ₹1.3 LakhRevenue · FY 2025 · -91% YoY
- ₹9,960Net profit · 8% margin
- ₹16,985EBITDA · 13% margin
- ₹2.5 LakhPaid-up capital
- +3%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Legene Biosciences Private Limited are on its company page.
Detailed financial statements for Eminent Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eminent Biosciences
Eminent Biosciences was founded in 2008.
Eminent Biosciences is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.
The primary company behind Eminent Biosciences, Legene Biosciences Private Limited, reported revenue of ₹1.3 Lakh for FY 2025, down 91% year on year.
Eminent Biosciences is a private research organization established in 2008, focusing on biotechnology, bioinformatics, and healthcare informatics. It delivers services like next-generation sequencing, data analysis, and microbial informatics to support life science and pharma industries. Based primarily in Indore, India, with a US presence, it emphasizes high-performance computing and training for researchers, ensuring quality and reliability in computational biology.
Eminent Biosciences offers PDB Explorer, KodDNA, and Journal Search Engine.
Eminent Biosciences operates through Legene Biosciences Private Limited.
The legal entities of Eminent Biosciences currently have 2 directors, including Rini Krishnan Karthikeyan, Anuraj Nayarisseri.